Alzheimer's Research is Major Beneficiary of $50 Million Grant

Nikolai Slavov, founder of Parallel2 Technology Institute, says the funding will be a “game changer” in understanding Alzheimer’s.

Related Keywords

United States ,Watertown ,Massachusetts ,Manhattan ,New York ,Northeastern University ,Americans ,Nikolai Slavov ,Eric Schmitt ,Ken Griffin ,Wendy Schmitt ,Bogdan Budnik ,Harrison Specht ,Aleksandra Petelski ,Josephe Aoun ,Technology Institute ,Convergent Research ,Allen Frontiers Group ,Human Proteome Organization ,Schmidt Futures ,Parallel Squared Technology Institute ,Eve Bio ,Proteome Organization ,Massachusetts General Hospital ,